Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

PRA Health Sciences Inc. (PRAH)

102.87   -0.24 (-0.23%) 09-20 01:42
Open: 103.32 Pre. Close: 103.11
High: 103.795 Low: 101.075
Volume: 757,629 Market Cap: 6,580M
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. The company is headquartered in Raleigh, North Carolina and currently employs 16,400 full-time employees. The firm provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The firm offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The company provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The firm's service offerings include product registration, strategic solutions and early development services.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 104.011 - 104.636 104.636 - 105.101
Low: 99.584 - 100.409 100.409 - 101.022
Close: 101.776 - 103.006 103.006 - 103.919

Technical analysis

as of: 2020-09-18 4:34:39 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 126.18     One year: 147.38
Support: Support1: 100.96    Support2: 96.59
Resistance: Resistance1: 108.03    Resistance2: 126.18
Pivot: 103.40
Moving Average: MA(5): 104.47     MA(20): 103.16
MA(100): 99.84     MA(250): 98.93
MACD: MACD(12,26): 0.13     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 58.07     %D(3): 68.17
RSI: RSI(14): 49.20
52-week: High: 113.32  Low: 58.67  Change(%): -2.4
Average Vol(K): 3-Month: 29354  10-Days: 32491

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PRAH has closed above bottom band by 45.4%. Bollinger Bands are 9.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 18 Sep 2020
Will PRA Health Sciences Inc (PRAH) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Fri, 18 Sep 2020
PRA Health Sciences Inc (NASDAQ:PRAH) Sees Significant Increase in Short Interest - MarketBeat

Fri, 18 Sep 2020
PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials - GlobeNewswire

Tue, 15 Sep 2020
PRA Health Sciences Announces Appointment of New Director - GlobeNewswire

Mon, 14 Sep 2020
Hedge Funds Dipping Their Toes Back Into PRA Health Sciences Inc (PRAH) - Yahoo Finance

Mon, 14 Sep 2020
These 4 Measures Indicate That PRA Health Sciences (NASDAQ:PRAH) Is Using Debt Reasonably Well - Simply Wall St

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 64
Shares Float (M) 64
% Held by Insiders 0.25
% Held by Institutions 99.87
Shares Short (K) 936
Shares Short P. Month (K) 1,020

Stock Financials

EPS 3.270
EPS Est This Year 3.200
EPS Est Next Year 3.930
Book Value (p.s.) 18.250
Profit Margin 6.86
Operating Margin 9.92
Return on Assets (ttm) 5.4
Return on Equity (ttm) 18.2
Qtrly Rev. Growth -4.4
Gross Profit (p.s.) 23.921
Sales Per Share 48.311
EBITDA (p.s.) 6.731
Qtrly Earnings Growth -66.30
Operating Cash Flow (M) 345
Levered Free Cash Flow (M) 274

Stock Valuations

PE Ratio 31.46
PEG Ratio 2.05
Price to Book value 5.64
Price to Sales 2.13
Price to Cash Flow 19.08

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.